FDA Warning Letter — Exxon 393

Case 669651 — FEI 3029257387

The FDA took a Warning Letter action against Exxon 393 on Oct 17, 2023 (Scranton, PA). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Exxon 393
Date
Oct 17, 2023
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Scranton, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.